TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›WRB

WRB

BERKLEY W R CORP

Next earnings Jul 16, 2026 (after close) · consensus $1.10 EPS, $3.80B rev

Last earnings -1.2% on 2026-04-21

Hold
$72.08
▲ +1.51%
$72.08▲ +1.56%
over 1Y
L $63.54H $77.13
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+1.5%
1W+4.0%
1M+10.6%
3M+9.2%
YTD+4.1%
1Y+1.6%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
B+
Valuation
Fair value
Filings
Clean
Hold
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 27 analysts
Hold

Best-in-class commercial insurer compounding book value at 18% ROE, but a softening rate cycle caps upside at 16x earnings.

Return on equity 18.3% · FY2025

The read

Fundamentals and price both look middling — no strong edge either way.

W. R. Berkley is a high-quality, decentralized commercial-lines P&C underwriter throwing off the kind of numbers that justify ownership: FY2025 revenue $14.7B (+7.8%), an 18.3% return on equity, a 12.1% net margin, and stockholders' equity up 15.6% to $9.70B. The five-year arc is genuinely impressive — revenue has compounded from $9.46B (2021) to $14.7B and net income from $1.02B to $1.78B — and management is returning the cash, with dividends paid up 31.6% to $700M plus $270M of buybacks against a shrinking share count. Operating cash flow of $3.58B and a growing $2.54B cash balance give it ample financial flexibility; the 3.54x liabilities/equity is normal leverage for an insurer, not a balance-sheet flag.

The catch is what the filing tells you the numbers are about to do. FY2025 net income grew only +1.3% and diluted EPS +2.1% even as revenue rose +7.8% — earnings are decelerating and margins are no longer expanding. The 10-K's Risk Factors and MD&A explain why: 'insurance rates have generally moderated for many lines of business, particularly for property lines, which in some instances are experiencing rate decreases,' and 'rates for workers' compensation and certain professional liability lines of business continue to decrease.' That is the textbook description of a softening (less profitable) phase of the underwriting cycle. Because P&C premiums are 'priced before its costs are known,' a soft market plus persistent social/economic inflation on loss costs is exactly when prior-year reserve adequacy gets tested — and the MD&A flags reserves for losses as its single most subjective critical estimate.

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 29, 2026, 8:28 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$9.46B$11.2B$12.1B$13.6B$14.7B
Gross profit—————
Operating income—————
Net income$1.02B$1.38B$1.38B$1.76B$1.78B
Diluted EPS$3.66$3.29$3.37$4.36$4.45
Net margin10.8%12.4%11.4%12.9%12.1%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF7.6
PEG (trailing)12.21
Earnings yield6.6%
FCF yield13.1%

Quality & risk

ROIC (est.)—
Free cash flow$3.52B
Total debt—
Net cash$2.54B
Piotroski F-Score4/6

Capital returns

Buyback yield1.0%
Dividend yield (est.)2.6%
Shareholder yield3.6%
Shares Δ YoY-1.2%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has been improving.
  1. 8-K Officer / director change2026-06-26

    Item 5.02: leadership change — an officer or director was appointed or departed

  2. 8-K Material agreement2026-06-11

    Issued new senior notes/debt, adding a financial obligation to fund operations

  3. 8-K Other event2026-06-10

    Item 8.01 other-event disclosure (likely dividend/capital action); no core-ops change

  4. 8-K Shareholder vote2026-06-05

    Reported annual-meeting voting results; directors/proposals carried as expected

  5. 10-Q Quarterly report2026-05-01

    Q1 2026 10-Q: equity and premiums grew; investment income stayed strong

  6. DEF 14A Proxy statement2026-04-22

    2026 proxy: board slate, exec comp and say-on-pay for shareholder vote

  7. 8-K Earnings results2026-04-21

    Q1 2026 earnings release — continued premium and book-value growth

  8. 10-K Annual report2026-02-27

    FY2025 10-K: record $14.7B revenue, equity +15.6%, dividends +31.6%

  9. 8-K Earnings results2026-01-26

    FY2025 earnings — record revenue $14.7B and EPS $4.45, ROE 18.3%

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-262026-06-26open ↗11-KPeriod ending 2025-12-312026-06-25open ↗8-KPeriod ending 2026-06-092026-06-11open ↗8-KPeriod ending 2026-06-092026-06-10open ↗8-KPeriod ending 2026-06-032026-06-05open ↗SCHEDULE 13D/AFiling2026-06-04open ↗4Period ending 2026-06-032026-06-04open ↗4Period ending 2026-06-032026-06-04open ↗4Period ending 2026-06-032026-06-04open ↗4Period ending 2026-06-032026-06-04open ↗4Period ending 2026-06-032026-06-04open ↗4Period ending 2026-06-032026-06-04open ↗

Quality score

B+
ValueGrowthProfitHealthMom.
ValueA-
GrowthC+
ProfitabilityA-
Financial healthA-
MomentumB-
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✓Return on equity above 15%
  • ✓P/E below 25

Fair value est.

$75.25

Fairly valued +4% vs price

cheapfair valueexpensive

Modified Graham: EPS $4.45 × (8.5 + 1.5 × 4.6% growth) × 1.10 quality = 16.9× multiple. An estimate, not a price target.

62.9752-week76.44
Revenue
$14.7B
+7.8% YoY
Net margin
12.1%
ROE
18.3%
P/E
16.2

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$14.7B+7.8%
Net income$1.78B+1.3%
Diluted EPS$4.45+2.1%
Cash & equivalents$2.54B+28.6%
Total assets$44.1B+8.6%
Total liabilities$34.4B+6.8%
Stockholders' equity$9.70B+15.6%
L/E: 3.54x

Frequently asked

Is BERKLEY W R CORP (WRB) a buy?
WRB currently carries a Hold rating with 4/5 conviction, derived from its latest SEC filings. Best-in-class commercial insurer compounding book value at 18% ROE, but a softening rate cycle caps upside at 16x earnings.
What is WRB's fair value?
A Modified-Graham model based on WRB's SEC fundamentals estimates a fair value of about $75.25. It is an estimate from reported earnings, not a price target.
Is WRB overvalued or undervalued?
Against a Modified-Graham fair-value estimate, WRB currently appears fairly valued relative to its SEC-grounded earnings power.
What is BERKLEY W R CORP's quality score?
WRB scores 75.15238338084656/100 (grade B+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000011544, latest 10-Q filed 2026-05-01) · EODHD · Proprietary analysis · as of 6/29/2026, 12:28:45 PM.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-06-03
BERKLEY WILLIAM R
Executive Chairman
Award3.09K
2026-06-03
Ferre Maria Luisa
Director
Award3.09K
2026-06-03
Mattson Marie Angela
Director
Award3.09K
2026-06-03
BERKLEY WILLIAM R JR
President and CEO
Award3.09K
2026-06-03
Mosley Daniel Lynn
Director
Award3.09K
2026-06-03
Farrell Mary C
Director
Award3.09K
2026-06-03
Rusbuldt Robert Alan
Director
Award3.09K
2026-06-03
Augostini Christopher L
Director
Award3.09K

Dividends

Quarterly
Yield (TTM)
2.6%
Annual / share
$1.87
Last ex-date
2026-06-23
Last amount
$0.60
ex 2026-06-23paid 2026-07-02$0.60
ex 2026-02-23paid 2026-03-04$0.09
ex 2025-12-15paid 2025-12-29$1.09
ex 2025-09-22paid 2025-09-30$0.09
ex 2025-06-23paid 2025-06-30$0.59
ex 2025-03-03paid 2025-03-12$0.08

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-04-21Beat +12.4% est▼ -1.21%8-K ↗
2026-01-26Miss -0.7% est▼ -0.36%8-K ↗
2025-10-20Miss -0.5% est▼ -0.77%8-K ↗
2025-07-21Beat +1.2% est▼ -1.38%8-K ↗
2025-04-21—▼ -2.14%8-K ↗
2025-01-27—▲ +2.92%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

10 sells · 1 member · last 180d

−$80.0K net soldlast trade 30d ago
$0.00 bought$80.0K sold
2026-07-02Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2026-06-08Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2026-06-08Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2026-06-08Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2026-06-08Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2026-06-08Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2026-06-08Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2026-04-07Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2026-02-13Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2026-02-13Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2025-11-21Lisa McClainBuy$1.00K–$15.0KPTR ↗
2025-11-21Lisa McClainSell$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Recent news

market news →
CB Stock Outperforms Industry, Trades Near 52-Week High: Time to Exit?Bullish
finance.yahoo.com· 2026-07-01
WRB Stock Trades Above 200-Day SMA: What Should Investors Do?Bullish
finance.yahoo.com· 2026-07-01
W. R. Berkley (WRB) Is Up 6.1% After Dividend Hike, Buyback Reset And Rating Upgrade - Has The Bull Case Changed?Bullish
finance.yahoo.com· 2026-06-28
W. R. Berkley Earnings Preview: What to ExpectBullish
finance.yahoo.com· 2026-06-26
AM Best Upgrades Issuer Credit Ratings of W. R. Berkley Corporation and Its SubsidiariesBullish
finance.yahoo.com· 2026-06-25
W. R. Berkley Corporation Names John Enright President of Berkley Specialty LondonBullish
finance.yahoo.com· 2026-06-25

Vs Financials peers

compare →

185 tracked peers · median

TENK Score75 vs 73
Revenue growth7.8% vs 7.5%
Net margin12.1% vs 21.5%
Return on equity18.3% vs 12.1%
P/E16.2 vs 15.3
Peers
WTMJHGRNRALLPRIPGROMFSLM

News sentiment

EODHD · 26d
Bullish
+0.12
vs typical · 38 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.